[CALT] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[CALT] Calliditas Therapeutics AB (publ)
Announcement Date
29-Sep-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- 95.27%
YoY- -241.26%
Quarter Report
CALT's Result
CALT's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 269,384 191,352 429,042 260,056 64,047 49,734 31,180 322.71%
PBT -70,660 -208,019 10,066 -15,958 -192,090 -211,434 -218,467 -52.97%
Tax 21,274 -20,494 13,747 -6,848 339 -4,387 199 2171.85%
NP -91,934 -187,525 -3,681 -9,110 -192,429 -207,047 -219,170 -44.05%
Tax Rate - - -136.57% - - - - -
Total Cost 361,318 378,877 432,723 269,166 256,476 256,781 250,350 27.79%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin -34.13 -98.00 -0.86 -3.50 -300.45 -416.31 -702.92 -86.76%
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -1.71 -3.49 -0.07 -0.34 -7.24 -7.91 -8.37 -65.41%
EPS Diluted -1.71 -3.49 -0.07 -0.34 -7.24 -7.91 -8.37 -65.41%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.